| Name | Title | Contact Details |
|---|---|---|
Sheerin Siddique |
Associate General Counsel | Profile |
ProKidney, a pioneer in the treatment of chronic kidney disease (CKD) through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney`s lead product candidate, REACT® (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular therapy with the potential to not only slow and stabilize the progression of CKD, but in some cases drive meaningful improvement in kidney function. REACT® has received Regenerative Medicine Advanced Therapy (RMAT) designation, as well as FDA and EMA guidance, supporting an immediate start to a global registrational program, which launched in the United States on schedule in January 2022. On January 18, 2022, ProKidney announced that it would become a publicly traded company via a business combination with Social Capital Suvretta Holdings Corp. III
Westside Health Inc is a Wilmington, DE-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
MedAvante, Inc. is a Trenton, NJ-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
EMSI Acquired Leprechaun is a Fort Worth, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
With nearly 5,000 employees comprising Acadian Ambulance, Acadian Air Med, National EMS Academy, Acadian Total Security, Safety Management Systems and Executive Aircraft Charter Service, Acadian Companies provides a diverse suite of services that offer the very best support and education in health, safety and transportation.